About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02159378

Fructosamines and Gestational Diabetes (FRUCTO)

The prevalence of gestational diabetes is estimated at between 2 and 6%, but can be much higher in specific populations. The specific treatment of gestational diabetes (diet, control weight gain, sel...

Lead sponsor: Centre Hospitalier Departemental Vendee•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre Hospitalier Departemental Vendee

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Age ≥18 years
•Ongoing pregnancy with a start date of pregnancy known and confirmed by an ultrasound of the 1st Quarter performed between 10 and 14 weeks with measurement of the crown-rump length
•Hospitalization for a GD's discovery whatever the term of pregnancy (GD is defined with nationals recommendations of CNGOF)
•Not opposed to participate in the study

Exclusion Criteria

•Pregnancy uncertain term (absence of early ultrasound)
•Previous diabetes to the pregnancy (type 1 or 2)
•Multiple Pregnancy
•No affiliation to a social security scheme
•Woman with a measure of legal protection

Related studies

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

Navigating Pregnancy and Parenthood With Lyme Disease

NCT06397794 · Lyme Disease, Post Treatment Lyme Disease, and more

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety

NCT07233278 · Recurrent Pregnancy Loss(RPL), Anxiety

RECRUITINGPhase 3

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

NCT05569772 · Glucose Intolerance After a Recent History of Gestational Diabetes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 17, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment200

Start dateJul 2014

Last updatedNov 17, 2025

Condition

Pregnancy Gestational Diabetes

Locations shown

Centre hospitalier départemental Vendée

La Roche-sur-Yon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 17, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions